LGMN and neoplasm: Responsive surface engineered Mφ‐based platforms for efficiently delivering an anticancer agent to the tumor cells or working by itself as triggered immune cells have been employed as a promising strategy for the eradication of tumor cells.[94] It is known that legumain is highly expressed in the tumor tissue.